Julien Rohmer

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 290 citations · Full text

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +9

Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers

François‐Xavier Danlos, Claudia Grajeda‐Iglesias, Sylvère Durand et al. · Cell Death and Disease · 2021 · 161 citations · Full text

Monocyte/Macrophage Abnormalities Specific to Rheumatoid Arthritis Are Linked to miR-155 and Are Differentially Modulated by Different TNF Inhibitors

Audrey Paoletti, Julien Rohmer, Bineta Ly et al. · The Journal of Immunology · 2019 · 67 citations · Full text

Immunology, Pathology, Monocyte/macrophage Abnormalities Specific +19

Epidemiology, clinical picture and long‐term outcomes of<i>FIP1L1‐PDGFRA</i>‐positive myeloid neoplasm with eosinophilia: Data from 151 patients

Julien Rohmer, Amélie Couteau‐Chardon, Julie Trichereau et al. · American Journal of Hematology · 2020 · 66 citations

Venous thrombosis and predictors of relapse in eosinophil-related diseases

Valériane Réau, Alexandre Vallée, Benjamin Terrier et al. · Scientific Reports · 2021 · 34 citations · Full text